Incannex Healthcare Limited (IXHL) vs Nephros, Inc. (NEPH)

A side-by-side comparison of Incannex Healthcare Limited and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IXHL vs NEPH

growth of $100 · dividends reinvested · last 5y
IXHL -99.8% (-71.8%/yr)NEPH -20.2% (-4.4%/yr)NEPH compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002023202420252026$0$80
IXHL NEPH

IXHL vs NEPH: by the numbers

  • •NEPH is the larger company ($38M vs $38M market cap).
  • •NEPH is profitable (8.38% net margin) while IXHL runs a net loss (0.00%).

Metrics side by side

Valuation

MetricIXHLNEPH
P/E ratioN/A22.12
Forward P/EN/A22.40
P/S ratioN/A1.84
P/B ratio0.563.18
EV / EBITDAN/A19.42

Profitability

MetricIXHLNEPH
Gross margin0.00%60.31%
Operating margin0.00%7.92%
Net margin0.00%8.38%
ROE-28.65%14.51%
ROIC-32.18%12.67%

Growth (annualized)

MetricIXHLNEPH
Revenue CAGR (5Y)N/A16.99%
Total return CAGR (5Y)N/A-15.93%

Frequently asked

Is IXHL or NEPH more profitable?
NEPH runs the higher net margin — IXHL at 0.00% versus NEPH at 8.38%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.